Particle-induced myeloperoxidase release in serially diluted whole blood quantifies the number and the phagocytic activity of blood neutrophils and opsonization capacity of plasma

Luminescence

Volumn 21, Issue 3, 2006, Pages 148-158

  Lilius, Esa Matti Eino ^a   Nuutila, Jari Timo Juhani ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Chemiluminescence; Luminol; Myeloperoxidase; Neutrophil

Indexed keywords

BLOOD; CHLORINE COMPOUNDS; DIAGNOSIS;

BACTERIAL INFECTIONS; BLOOD CONTENT; LUMINOLS; MYELOPEROXIDASE; NEUTROPHILE; OPSONIZED ZYMOSAN; PHAGOCYTIC ACTIVITY; REACTION VOLUME; VIRAL INFECTIONS; WHOLE BLOOD;

CHEMILUMINESCENCE;

BACTERIA (MICROORGANISMS);

EID: 33745407064     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.899     Document Type: Article

References (53)

1. Allen RC, Stjernholm RL, Steele RH. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem. Biophys. Res. Commun. 1972; 47(4): 679-684.
2. Rosen H, Klebanoff SJ. Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes. J. Clin. Invest. 1976; 58(1): 50-60.
3. Lilius EM, Marnila P. Photon emission of phagocytes in relation to stress and disease. Experientia 1992; 48(11-12): 1082-1091.
4. Cohen MS, Shirley PS, DeChatelet LR. Further evaluation of luminol-enhanced luminescence in the diagnosis of disorders of leukocyte oxidative metabolism: role of myeloperoxidase. Clin. Chem. 1983; 29(3):513-515.
5. Aniansson H, Stendahl O, Dahlgren C. Comparison between luminol- and lucigenin-dependent chemiluminescence of polymorphonuclear leukocytes. Acta Pathol. Microbiol. Immunol. Scand. C 1984; 92(6): 357-361.
6. Dahlgren C, Stendahl O. Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun. 1983; 39(2): 736-741.
7. Briheim G, Stendahl O, Dahlgren C. Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect. Immun. 1984; 45(1): 1-5.
8. Gerber CE, Kuci S, Zipfel M, Niethammer D, Bruchelt G. Phagocytic activity and oxidative burst of granulocytes in persons with myeloperoxidase deficiency. Eur. J. Clin. Chem. Clin. Biochem. 1996; 34(11): 901-908.
9. Stendahl O, Andersson T, Dahlgren C, Magnusson KE. Defective chemiluminescence response in differentiated HL60 cells due to impaired degranulation. Biochim. Biophys. Acta 1986; 881(3): 430-436.
10. Edwards SW, Hart CA, Davies JM, Pattison J, Hughes V, Sills JA. Impaired neutrophil killing in a patient with defective degranulation of myeloperoxidase. J. Clin. Lab. Immunol. 1988; 25(4): 201-206.
11. Dahlgren C, Follin P, Johansson A, Lock R, Orselius K. Localization of the luminol-dependent chemiluminescence reaction in human granulocytes. J. Biolumin. Chemilumin. 1989; 4(1): 263-266.
12. Mills EL, Rholl KS, Quie PG. Luminol-amplified chemiluminescence: a sensitive method for detecting the carrier state in chronic granulomatous disease. J. Clin. Microbiol. 1980; 12(1): 52-56.
13. Ritchey EE, Wallin JD, Shah SV. Chemiluminescence and Superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int. 1981; 19(2): 349-358.
14. Kossack RE, Guerrant RL, Densen P, Schadelin J, Mandell GL. Diminished neutrophil oxidative metabolism after phagocytosis of virulent Salmonella typhi. Infect. Immun. 1981; 31(2): 674-678.
15. Horan TD, Noujaim AA, McPherson TA. Effect of indomethacin on human neutrophil chemiluminescence and microbicidal activity. Immunopharmacology 1983; 6(2): 97-106.
16. Sheng ZY, Tung YL. Neutrophil chemiluminescence in burned patients. J. Trauma 1987; 27(6): 587-595.
17. Edwards SW, Say JE, Hart CA. Oxygen-dependent killing of Staphylococcus aureus by human neutrophils. J. Gen. Microbiol. 1987; 133(12): 3591-3597.
18. Yoneda M, Maeda K, Aono M. Suppression of bactericidal activity of human polymorphonuclear leukocytes by Bacteroides gingivalis. Infect. Immun. 1990; 58(2): 406-411.
19. Brar DW, Borden EC, Proctor RA. Recombinant interferon-gamma preserves human granulocyte bactericidal and chemoluminescence activities. J. Infect. Dis. 1993; 168(1): 128-134.
20. Uehara M, Sato N. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma. Hepatology 1994; 20(2): 326-330.
21. Kubo S, Matsumoto T, Takahashi K, Haraoka M, Tanaka M, Sakumoto M, Sakamoto Y, Kumazawa J. Enhanced chemiluminescence response of polymorphonuclear leukocytes by new quinolone antimicrobials. Chemotherapy 1994; 40(5): 333-336.
22. Zahler S, Kowalski C, Brosig A, Kupatt C, Becker BF, Gerlach E. The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. J. Immunol. Methods 1997; 200(1-2): 173-179.
23. Pauksens K, Sjolin J, Venge P. Chemiluminescence of polymorphonuclear leukocytes and whole blood during acute bacterial infection. Scand. J. Infect Dis. 1989; 21(3): 277-284.
24. Fujisawa M, Kojima K, Beppu T, Futagawa S, Kuwahara K, Hiramatsu K. Early diagnosis of postoperative infection: assessment of whole blood chemiluminescence. Surg. Today 2000; 30(4): 309-318.
25. Korhonen PA, Lilius EM, Hyyppa S, Rasanen LA, Poso AR. Production of reactive oxygen species in neutrophils after repeated bouts of exercise in standardbred trotters. J. Vet. Med. A Physiol. Pathol. Clin. Med. 2000; 47(9): 565-573.
26. van Antwerpen VL, Theron AJ, Richards GA, Steenkamp KJ, van der Merwe CA, van der Walt R, Anderson R. Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and non-smokers. Free Radic. Biol. Med. 1995; 18(5): 935-941.
27. Nordman SA, Nyberg PW. Whole blood chemiluminescence as a systemic inflammatory parameter in asthma. J. Allergy Clin. Immunol. 1994; 94(5): 853-860.
28. Gallacher SJ, Thomson G, Fraser WD, Fisher BM, Gemmell CG, MacCuish AC. Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet. Med. 1995; 12(10): 916-920.
29. Ristola M, Metsa-Ketela T, Leirisalo-Repo M, Repo H. Oxygen radical production and trapping in subjects with previous Yersinia infection. Inflammation 1992; 16(3): 273-283.
30. Trulson A, Nilsson S, Venge P. Lucigenin-enhanced chemiluminescence in blood is increased in cancer. Am. J. Clin. Pathol 1989; 91(4): 441-445.
31. Allen RC. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 1986; 133: 449-493.
32. Nimeri G, Ohman L, Elwing H, Wettero J, Bengtsson T. The influence of plasma proteins and platelets on oxygen radical production and F-actin distribution in neutrophils adhering to polymer surfaces. Biomaterials 2002; 23(8): 1785-1795.
33. Diem K, Lentner, C. Scientific Tables. Ciba-Geigy Ltd: Basel, Switzerland, 1971; 809 pp.
34. Loimaranta V, Nuutila J, Marnila P, Tenovuo J, Korhonen H, Lilius EM. Colostral proteins from cows immunized with Streptococcus mutans/S. sobrinus support the phagocytosis and killing of mutans streptococci by human leucocytes. J. Med. Microbiol. 1999; 48(10): 917-926.
35. Cheson BD, Morris SE. The role of complement and IgG on zymosan opsonization. Int. Arch. Allergy Appl. Immunol. 1981; 66(1): 48-54.
36. Lilius E-M, Nuutila J. Kinetics of luminol-amplified chemiluminescence in relation to phagocytosis of zymosan and its opsonized varieties in human neutrophils. In 7th International Symposium of Bioluminescence and Chemiluminescence, Szalay A, Kricka L, Stanley P (eds). Wiley: Chichester; 1993; 465-469.
37. Murata T, Sullivan JA, Sawyer DW, Mandell GL. Influence of type and opsonization of ingested particle on intracellular free calcium distribution and Superoxide production by human neutrophils. Infect. Immun. 1987; 55(8): 1784-1791.
38. Nurnberger W, Willers R, Schroten H, Bunning G, Gobel U, Wahn V. [Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. II. Zymosan opsonization is decreased and is not increased by IgG infusions]. Monatsschr. Kinderheilkd. 1988; 136(4): 181-185.
39. Williams AJ, Hastings MJ, Easmon CS, Cole PJ. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence. Immunology 1980; 41(4): 903-911.
40. Lilius EM, Nykänen J, Ståhlberg M-R. Leukocytes as immunosensors: a screening method for food intolerances. In Bioluminescence and chemiluminescence. 4th International Symposium of Bioluminescence and Chemiluminescence, Schölmerich J, Andreesen R, Kapp A, Ernst M, Woods WG (eds). Wiley: Chichester, 1987; 145-148.
41. Del Principe D, Menichelli A, D'Arcangelo C, Strappini PM, Persiani M, Colistra C, Scarpati ML. Opsonized-zymosan induces a respiratory burst in human blood platelets. Am. J. Hematol. 1983; 15(4): 353-360.
42. Clawson CC, Rao GH, White JG. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am. J. Pathol. 1975; 81(2): 411-420.
43. Ruf A, Schlenk RF, Maras A, Morgenstern E, Patscheke H. Contact-induced neutrophil activation by platelets in human cell suspensions and whole blood. Blood 1992; 80(5): 1238-1246.
44. Bos A, Wever R, Roos D. Characterization and quantification of the peroxidase in human monocytes. Biochim. Biophys. Acta 1978; 525(1): 37-44.
45. Bekesi G, Kakucs R, Varbiro S, Feher J, Pazmany T, Magyar Z, Sprintz D, Szekacs B. Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. BJOG 2001; 108(5): 474-481.
46. Christensen RD, Rothstein G. Neutrophil myeloperoxidase concentration: changes with development and during bacterial infection. Pediatr. Res. 1985; 19(12): 1278-1282.
47. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. J. Am, Med. Assoc. 2001; 286(17): 2136-2142.
48. van Eeden SF, Hogg JC. The response of human bone marrow to chronic cigarette smoking. Eur. Resp. J. 2000; 15(5): 915-921.
49. Nuutila J, Lilius E-M. Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytometry 2005 (in press).
50. Peake J, Wilson G, Hordern M, Suzuki K, Yamaya K, Nosaka K, Mackinnon L, Coombes JS. Changes in neutrophil surface receptor expression, degranulation, and respiratory burst activity after moderate- and high-intensity exercise. J. Appl. Physiol. 2004; 97(2): 612-618.
51. Conese M, Copreni E, Di Gioia S, De Rinaldis P, Fumarulo R. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease. J. Cyst. Fibros. 2003; 2(3): 129-135.
52. Monteseirin J, Bonilla I, Camacho J, Conde J, Sobrino F. Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J. Allergy Clin. Immunol. 2001; 107(4): 623-626.
53. Carlson M, Hakansson L, Peterson C, Stalenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J. Allergy Clin. Immunol. 1991; 87(1, 1): 27-33.